- Definition

The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.

+ References+ Details

Commitments and contingencies - Additional information (Details) (USD $) In Thousands, unless otherwise specified	1 Months Ended
	Feb. 20, 2013	Mar. 24, 2014 Advantar Laboratories, Inc. [Member]	Feb. 20, 2013 Sublicensed Technology [Member]	Feb. 20, 2013 Licensed Product [Member]	Mar. 31, 2014 Rostislav Raykov
Issue Of Convertible Common Stock As Per License Agreement.	13,902
Expired Convertible Common Stock	21,250
Royalty Percent			5.00%	2.50%
Discount On Royalty Percent				1.00%
Minimum Amount To Be Bought To Get Discount On Royalty				$ 150
Milestone Payment Fees	100
Research and Development Expense, Total		42
Severance Costs Payable In Case Of Termination Other Than For Cause					$ (160)